Bhutan: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
The project will provide the Government of Bhutan with immediate and flexible financing to support its national coronavirus disease (COVID-19) vaccination program through the Asia Pacific Vaccine Access Facility (APVAX) of the Asian Development Bank. The APVAX allocation comprises the rapid response component to support the purchase of the APVAX-eligible COVID-19 vaccines. The project investment component financed by the JFPR grant will strengthen the disease surveillance, while enhancing the accessibility of essential health care services and immunization.Strengthening Bhutan's booster vaccination will contribute toward reducing cross-border health risks.
| PROJECT DETAILS | ||
|
Commitment Date Funding Type Country Sector Status Total Cost |
5 Aug 2022 Loan/Grant Bhutan Health Ongoing $15.15 million | |
| KEY OUTPUTS |
Delivery of safe and effective COVID-19 vaccines Improved accessibility of PHC and immunization services, and disease surveillance capacity |
| FINANCING |
$10 million (Asian Development Bank Ordinary Capital Resources) $3 million (Japan Fund for Prosperous and Resilient Asia and the Pacific) $2.15 million (Government of Bhutan) |
